These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 8638647
1. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin. Amiral J, Peynaud-Debayle E, Wolf M, Bridey F, Vissac AM, Meyer D. Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647 [Abstract] [Full Text] [Related]
2. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia]. Amiral J. Ann Med Interne (Paris); 1997 Jun; 148(2):142-9. PubMed ID: 9238439 [Abstract] [Full Text] [Related]
3. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D. Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492 [Abstract] [Full Text] [Related]
9. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367 [Abstract] [Full Text] [Related]
10. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. Legnani C, Cini M, Pili C, Boggian O, Frascaro M, Palareti G. Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902 [Abstract] [Full Text] [Related]
11. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. J Lab Clin Med; 2005 Dec; 146(6):341-6. PubMed ID: 16310517 [Abstract] [Full Text] [Related]
12. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Carrier M, Knoll GA, Kovacs MJ, Moore JC, Fergusson D, Rodger MA. Thromb Res; 2007 Dec; 120(2):215-20. PubMed ID: 17098277 [Abstract] [Full Text] [Related]
13. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs. Walenga JM, Jeske WP, Prechel MM, Bacher P, Bakhos M. Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468 [Abstract] [Full Text] [Related]
16. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407 [Abstract] [Full Text] [Related]
17. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies. Mattioli AV, Bonetti L, Carletti U, Ambrosio G, Mattioli G. Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851 [Abstract] [Full Text] [Related]